A pathogenic PrP mutation and doppel interfere with polarized sorting of the prion protein. by Uelhoff, A et al.
University of Zurich
Zurich Open Repository and Archive
Winterthurerstr. 190
CH-8057 Zurich
http://www.zora.unizh.ch
Year: 2005
A pathogenic PrP mutation and doppel interfere with polarized
sorting of the prion protein
Uelhoff, Armgard; Tatzelt, Jörg; Aguzzi, Adriano; Winklhofer, Konstanze F; Haass,
Christian
Uelhoff, Armgard; Tatzelt, Jörg; Aguzzi, Adriano; Winklhofer, Konstanze F; Haass, Christian. A pathogenic PrP
mutation and doppel interfere with polarized sorting of the prion protein. J. Biol. Chem. 2005, 280(7):5137-40.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
J. Biol. Chem. 2005, 280(7):5137-40
Uelhoff, Armgard; Tatzelt, Jörg; Aguzzi, Adriano; Winklhofer, Konstanze F; Haass, Christian. A pathogenic PrP
mutation and doppel interfere with polarized sorting of the prion protein. J. Biol. Chem. 2005, 280(7):5137-40.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
J. Biol. Chem. 2005, 280(7):5137-40
A pathogenic PrP mutation and doppel interfere with polarized
sorting of the prion protein
Abstract
Several proteins linked to neurodegenerative diseases, such as the beta-amyloid precursor protein,
amyloid beta-peptide, beta-secretase, and tau, undergo selective polarized sorting. We investigated
polarized sorting of the mammalian prion protein (PrP(C)) and its homologue doppel (Dpl). In contrast
to Dpl, which accumulates on the apical surface, PrP(C) is targeted selectively to the basolateral side in
Madin-Darby canine kidney cells. An extensive deletion and domain swapping analysis revealed that the
internal hydrophobic domain (HD) of PrP (amino acids 113-133) confers basolateral sorting in a
dominant manner. PrP mutants lacking the HD are sorted apically, while Dpl chimeras containing the
HD of PrP are directed to the basolateral membrane. Furthermore, a pathogenic PrP missense mutation
within the HD leads to aberrant apical sorting of PrP as well.
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Several proteins linked to neurodegenerative dis-
eases, such as the -amyloid precursor protein, amyloid
-peptide, -secretase, and tau, undergo selective polar-
ized sorting. We investigated polarized sorting of the
mammalian prion protein (PrPC) and its homologue
doppel (Dpl). In contrast to Dpl, which accumulates on
the apical surface, PrPC is targeted selectively to the
basolateral side in Madin-Darby canine kidney cells. An
extensive deletion and domain swapping analysis re-
vealed that the internal hydrophobic domain (HD) of
PrP (amino acids 113–133) confers basolateral sorting in
a dominant manner. PrP mutants lacking the HD are
sorted apically, while Dpl chimeras containing the HD
of PrP are directed to the basolateral membrane. Fur-
thermore, a pathogenic PrP missense mutation within
the HD leads to aberrant apical sorting of PrP as well.
A hallmark of prion diseases in humans and animals is the
conversion of the cellular prion protein PrPC into an abnor-
mally folded isoform, designated PrPSc, which is the major
component of infectious prions (reviewed in Refs. 1–4). How-
ever, transgenic animal models revealed that misfolding or
mistargeting of PrPC can induce neurodegeneration in the ab-
sence of infectious PrPSc, indicating that the neurotoxic agent
might be different from the infectious agent. For instance,
mutations in the hydrophobic domain (HD)1 of PrP, like A117V
and AV3 (alanines at positions 112, 114, and 117 replaced by
valines) lead to an aberrant folding of PrP during import into
the endoplasmic reticulum (ER) and induce neurodegeneration
in transgenic animals (5). Furthermore, neurodegeneration
without the formation of PrPSc was induced by cytosolic expres-
sion of PrPC (6). Of note, mistargeting of PrP to the cytosol was
described for PrP145Stop and PrP160Stop, two mutations
linked to inherited prion diseases in humans (7).
Spontaneous cerebellar neurodegeneration in certain strains
of PRNP0/0 mice led to the discovery of doppel (Dpl), a protein
structurally related to PrPC (8). Under physiological condi-
tions, Dpl is not expressed in the brain; however, ectopic neu-
ronal expression of Dpl induces Purkinje cell degeneration (9,
10). Dpl shows structural homology with the C-terminal glob-
ular domain of PrPC but lacks the N-terminal octarepeats and
the HD (11). Interestingly, expression of PrPF, a mutant
devoid of the octarepeats and the HD (32–134), induces cere-
bellar degeneration similarly to Dpl. Co-expression experi-
ments in transgenic animals revealed that full-length PrPC can
antagonize both Dpl- and PrPF-induced neurodegeneration
(10, 12).
Polarized sorting is an essential mechanism to establish and
maintain the physiological functions of neurons and epithelial
and endothelial cells. Selective trafficking is dependent on sort-
ing signals within the cargo protein itself, on the lipid compo-
sition of membranes, and on adapter proteins of the transport
machinery (reviewed in Refs. 13–16). Several proteins, which
play a fundamental role in neurodegenerative diseases, like the
-amyloid precursor protein (APP) (17–20), amyloid -peptide
(A) (17, 18), -secretase (BACE) (21), and tau (22), undergo
polarized sorting. Moreover, pathological conditions such as
the familial AD-associated Swedish mutation of APP affect
polarized sorting of BACE-generated soluble APP (23). While
the cellular targeting of AD-associated proteins has been stud-
ied in great detail, little is known about sorting of PrPC and its
homologue Dpl.
In this study we investigated the trafficking of PrPC and Dpl
in polarized cells and found that the two proteins, which are
both anchored to the plasma membrane via a glycosylphos-
phatidylinositol (GPI) anchor, are sorted differentially. We
identified the HD of PrPC as a dominant signal for basolateral
sorting. Moreover, we demonstrate that pathogenic mutations
within the HD and the expression of Dpl interfere with the
physiological sorting of PrPC.
EXPERIMENTAL PROCEDURES
cDNA Constructs—The coding region of mouse PRNP modified to
express PrP-L108M/V111M was inserted into the pcDNA3.1/Zeo vector
(Invitrogen), allowing detection by the 3F4 monoclonal antibody (24).
Generation of the PrP mutants PrPmtGPI, PrP-M204S, and PrPHD
was described previously (25). To generate a Dpl-expressing construct,
the coding region of mouse PRND was amplified by PCR and subcloned
into the pcDNA3.1/Zeo expression vector. For co-expression of PrP-3F4
and Dpl, the coding region of PrP-3F4 was amplified by PCR and
subcloned into the pcDNA6/V5-HisA/Blasticidin expression vector (In-
vitrogen). PrP-N/Dpl and PrP-HD/Dpl were generated by transferring
aa 1–133 or aa 113–133 of mouse PrP into the corresponding site in Dpl
by PCR techniques.
Cell Culture and Transfection—Madin-Darby canine kidney (MDCK)
cells (strain II) were maintained in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal bovine serum, antibiotics, and glutamine.
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Stable transfections of MDCK cells were performed with FuGENE as
described by the manufacturer. Cell lines expressing either PrP or Dpl
from pcDNA3.1/Zeo were selected with 200 g/ml zeocin; cell lines
co-expressing PrP and Dpl were selected with 200 g/ml zeocin and 2.5
g/ml blasticidin. Cell lines with moderate expression levels and nor-
mal morphology were chosen for the study. To obtain polarized mono-
layers for surface biotinylation, cells were plated at confluence on
24-mm polycarbonate transwell filters. Media were changed every day,
and cells were used for the corresponding experiment after 5 days. N2a
cells were cultivated and transfected as described earlier (26).
Antibodies—Monoclonal anti-PrP antibody 3F4 (27) was purchased
from Signet Pathology. The polyclonal anti-Dpl rabbit antiserum 2234
raised against recombinant Doppel was described earlier (10). Soluble
APP (APPs) was immunoprecipitated with polyclonal antibody 5313
raised against the ectodomain of APP (28) and immunoblotted with
monoclonal antibody 22C11 (Chemicon International).
Immunoprecipitation, Western Blotting, and Quantification Analy-
sis—Secreted PrP mutants present in the cell culture medium were
analyzed by immunoprecipitation (29) and subsequent Western blotting
(30). Quantification was performed using AIDA 3.26 image analysis
software (Raytest). The total amounts of protein located at/in the apical
and basolateral cell surface/medium was set as 100%, and quantifica-
tions were based on at least four independent experiments.
Trypsin, Endo H, and PNGase F Digestion—Trypsin and Endo H
digestions were described previoulsy (25). For PNGase F digestion,
protein lysates were adjusted to 0.1% SDS, 0.9% Triton X-100, digested
overnight at 37 °C and precipitated by trichloroacetic acid.
Surface Biotinylation—MDCK cell monolayers were washed with
cold PBS and incubated with sulfo-NHS-LC-biotin (1 mg/ml), either
apically or basolaterally for 1 h at 4 °C. 1% bovine serum albumin in
PBS was added to the opposite chamber. The reaction was stopped by
washing with PBS followed by quenching with 10 mM glycine in PBS.
Cells were lysed in cold lysis buffer (0.5% Triton X-100 and 0.5% sodium
deoxycholate in PBS) on ice for 30 min and scraped off the filter.
Lysates were clarified by centrifugation for 20 min at 14,000  g, and
proteins were precipitated with streptavidin-Sepharose. Biotinylated
proteins were detected by Western blotting. For the co-expression of
PrP and Dpl, lysates were immunoprecipitated using the 3F4 or 2234
antibody, respectively. The immunopellet was analyzed by Western
blotting using streptavidin-horseradish peroxidase conjugate. Re-
sults obtained by biotinylation were confirmed by indirect immuno-
fluorescence experiments.
RESULTS
PrPC and Dpl Are Differentially Sorted in Polarized Cells—
MDCK cells have been used successfully to study polarized
sorting of proteins linked to Alzheimer’s disease. We now used
this model system to study polarized trafficking of the mam-
malian PrPC and its homologue Dpl. Individual clones of stably
transfected MDCK cells expressing different levels of PrPC or
Dpl were selected (Fig. 1, A and B). Trafficking of PrPC and Dpl
was analyzed by cell surface biotinylation, which confirmed
that PrPC was selectively targeted to the basolateral mem-
brane (Fig. 1C), corroborating earlier results (31). Basolateral
sorting of PrPC is unexpected, since GPI-anchored proteins are
usually sorted to the apical surface (16, 32). Interestingly,
sorting of Dpl was distinct from PrPC sorting. Similarly to other
GPI-anchored proteins, Dpl was sorted to the apical membrane
of MDCK cells (Fig. 1D).
Co-expression of Dpl Targets PrPC to the Apical Membrane—
Neuronal expression of Dpl in PrPC-deficient mouse strains has
been shown to be responsible for cerebellar degeneration. In-
terestingly, co-expression of PrPC can counteract Dpl-induced
neurotoxicity (10, 33). An attractive model proposes that PrPC
and Dpl compete for a common ligand, and ligand binding to
Dpl in the absence of PrPC might initiate a neurotoxic cascade
(12, 34). However, a neutralizing activity of PrPC on Dpl-me-
diated neurodegeneration would be difficult to reconcile, since
we found PrPC and Dpl on opposite sites of MDCK cells.
To address this problem, we created cell lines stably express-
ing both PrPC and Dpl (Fig. 2A) and analyzed if co-expression
has an effect on the trafficking of PrPC or Dpl. Co-expression
did not interfere with the maturation of the individual pro-
teins. Both Dpl and PrPC were complex glycosylated and pres-
ent at the cell surface (Fig. 2B). Polarized sorting of Dpl was not
affected by the co-expression of PrPC, since Dpl was still found
predominantly at the apical membrane (Fig. 2C, -Dpl). In
contrast, Dpl expression had a profound effect on the sorting of
PrPC. Instead of being targeted to the basolateral site, PrPC
was found mainly at the apical membrane in the presence of
Dpl (Fig. 2C, -PrP). Notably, the effect of Dpl was selective for
PrPC, since in the presence of Dpl, APPs was still secreted from
the basolateral membrane (Fig. 2C, -APPs).
The Internal Hydrophobic Domain of PrPC Acts as a Domi-
nant Signal for Basolateral Sorting—To analyze polarized sort-
ing of PrPC mechanistically, we first addressed the role of the
membrane anchor and of the complexN-linked glycans, as both
post-translational modifications have been described to harbor
possible sorting signals (15). PrPC contains two partially sialy-
lated complex N-linked glycans (35). Two different mutants,
PrPmtGPI ( site for GPI anchor attachment mutated) and
PrP-M204S, are devoid of the GPI-anchor and are secreted into
the cell culture medium as high mannose glycoforms (25). Sim-
ilarly to wild type PrPC, these PrP mutants were sorted baso-
laterally and secreted into the basolateral chamber (Fig. 2D).
In comparison to PrPC, Dpl lacks the N-terminal unstruc-
tured region including the HD (Fig. 3A). Consequently, we
asked whether this domain could contain information required
for the basolateral sorting of PrPC. Two PrP-Dpl chimeras were
analyzed to address this question. PrP-N/Dpl contains the com-
plete N-terminal domain up to amino acid 133 of PrPC, while
FIG. 1. PrPC and Dpl are sorted differentially. MDCK cells were
stably transfected with either PrPC or Dpl. A and B, a Western blot
analysis is shown of total cell lysates from three independently estab-
lished PrPC or Dpl clones with different expression levels. Specificity of
antibodies used is shown by immunoblotting PrP clones with the poly-
clonal anti-Dpl antiserum 2234 (-Dpl) and Dpl clones with the mono-
clonal anti-PrP antibody 3F4 (-PrP). C and D, quantitative analysis of
polarized sorting of PrPC and Dpl. PrPC- (C) or Dpl- (D) expressing
clones shown in A and B were grown on filters for 5 days. Surface-
expressed PrPC or Dpl was selectively biotinylated from the apical (ap
apical) or basolateral (bl basolateral) side. Biotinylated proteins were
isolated from cell lysates using streptavidin-coated Sepharose and de-
tected by immunoblotting. The relative amount of PrPC or Dpl sorted to
the apical or basolateral side was determined from at least five inde-
pendent experiments. The total amount of PrPC or Dpl located on the
apical and basolateral cell surface was set as 100%. Of note, the sorting
behavior of either PrPC or Dpl was independent of expression levels.
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for the generation of PrP-HD/Dpl only the HD of PrPC (aa
113–133) was transferred to Dpl (Fig. 3A). First, we demon-
strated that PrP-HD/Dpl was present as a complex glycosy-
lated protein at the cell surface, suggesting that folding and
maturation was not impaired (Fig. 3B). PrP-N/Dpl showed the
same biochemical behavior (data not shown). However, polar-
ized sorting of the PrP-Dpl chimera was dramatically affected.
Dpl containing the N-terminal domain of PrPC was directed to
the basolateral membrane (Fig. 3C, PrP-N/Dpl). Moreover, the
HD of PrPC comprising 20 amino acids was sufficient to medi-
ate basolateral sorting of Dpl (Fig. 3C, PrP-HD/Dpl).
To confirm the role of the HD in the trafficking of PrPC, we
analyzed a PrP mutant lacking this internal stretch of hydro-
phobic amino acids. Deletion of the HD has no major effect on
the maturation of PrPC (25); however, PrPHD was found
mainly at the apical membrane, supporting the pivotal role of
the HD in basolateral sorting of PrPC (Fig. 3C, PrPHD). This
observation is consistent with the mistargeting of basolaterally
targeted proteins after deletion of the basolateral sorting signal
(see for example Ref. 17).
A Pathogenic Mutation Interferes with Physiological Sorting
of PrPC—After having identified the HD as a dominant sorting
signal for basolateral trafficking of PrPC, we wondered whether
pathogenic mutations located within this domain would affect
polarized sorting. Two mutations, A117V and AV3 (alanine
residues at positions 112, 114, and 117 replaced by valines)
(Fig. 3A), are linked to prion diseases in humans and trans-
genic mice, respectively (5). In previous studies the HD domain
was identified as a putative transmembran domain, and it was
shown that the AV3 mutation enhanced the formation of Ctm-
PrP, a transmembrane topology of PrP with the C terminus
facing the ER lumen (5). However, we could not detect a trans-
FIG. 2. Co-expression of Dpl directs PrPC to the apical side. A,
MDCK cells were stably transfected with both PrPC and Dpl. A Western
blot analysis is shown of total cell lysates from three independently
established MDCK clones co-expressing PrPC and Dpl with different
expression levels. B, biochemical analysis of PrPC and Dpl co-expressed
in MDCK cells. MDCK cells stably co-expressing PrPC and Dpl were
incubated on ice with trypsin to remove cell surface proteins or mock-
treated. After cell lysis, residual PrPC and Dpl were detected by West-
ern blotting. For analyzing the glycosylation status, cell lysates were
prepared and either incubated with Endo H, PNGase F, or mock-
treated prior to Western blotting. C, quantitative analysis of polarized
sorting of PrPC and Dpl co-expressed in MDCK cells. PrPC- and Dpl-
expressing clones shown in A were cell surface-biotinylated on the
apical or basolateral side. After cell lysis proteins were immunoprecipi-
tated and subsequently detected by Western blotting using a strepta-
vidin-horseradish peroxidase conjugate. The relative amount of PrPC or
Dpl sorted to the apical or basolateral side was determined from at least
four independent experiments. As a control, conditioned apical and
basolateral media were collected prior to cell surface biotinylation, and
immunoprecipitation was performed using the polyclonal anti-APPs
antibody 5313. Secreted endogenous APPs on either side of the polar-
ized monolayer was detected by immunoblotting using the monoclonal
anti-APPs antibody 22C11 (-APPs). D, basolateral sorting of PrPC is
independent of GPI anchoring and complex glycosylation. Polarized
sorting of PrPC was analyzed as described in the legend for Fig. 1, C and
D. For the analysis of PrP mutants, MDCK cells stably transfected with
either PrPmtGPI or PrP-M204S were grown on filters for 5 days.
Conditioned media were collected, and secreted PrP mutants were
immunoprecipitated and detected by immunoblotting. Quantification
shows the relative amount of PrPmtGPI or PrP-M204S secreted on
either side of the polarized monolayer, determined from at least six
independent experiments.
FIG. 3. The HD of PrPC acts as a dominant sorting signal. A,
schematic representation of the constructs analyzed. ER-SS, ER signal
sequence; OR, octarepeat region; HD, hydrophobic domain; 1–3, heli-
cal regions; 1,2, -strands; CHO, N-linked glycan attachment sites;
GPI-SS, glycosylphosphatidylinositol anchor signal sequence; black
boxes, domains of PrPC; white boxes, domains of Dpl. B, biochemical
characterization of PrP-HD/Dpl. N2a cells were transiently transfected
to express chimeric PrP-HD/Dpl. One day after transfection, cells were
incubated on ice with trypsin to remove cell surface proteins or mock-
treated. After cell lysis, residual PrP-HD/Dpl was detected by Western
blotting. For analyzing the glycosylation status, total cell lysates were
either incubated with Endo H, PNGase F, or mock-treated prior to
Western blotting. C, quantitative analysis of polarized sorting. Polar-
ized sorting of the different constructs in stably transfected MDCK cells
were analyzed as described in Fig. 1, C and D.
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membrane topology of PrP-AV3 at the cell surface (data not
shown). Strikingly, cell surface biotinylation and indirect im-
munofluorescence (data not shown) analysis revealed that in
contrast to PrPC, PrP-AV3 was predominantly found at the
apical membrane (Fig. 3C, AV3). Thus, a pathogenic mutation
within the HD affects polarized sorting of PrP.
DISCUSSION
Apical sorting of GPI-anchored proteins is thought to be
mediated by the GPI anchor itself, its association with lipid
microdomains, or N- and/or O-linked glycosylation (15, 32).
Remarkably, PrPC is to our knowledge the only GPI-anchored
protein, which is sorted to the basolateral membrane in polar-
ized MDCK cells. Our analysis showed that PrPC sorting is
independent of a membrane anchor and the glycosylation sta-
tus; secreted high mannose glycoforms of PrP lacking the GPI
anchor (PrPmtGPI, PrP-M204S) were efficiently sorted to the
basolateral side as well.
A clue to the sorting determinants of PrPC was obtained by
analyzing the PrPC homologue Dpl. This protein shows a struc-
tural organization similar to that of PrPC, but it lacks the
N-terminal region including the hydrophobic domain (11). Do-
main swapping experiments demonstrated that the HD of PrPC
confers basolateral sorting. Dpl containing either the whole
N-terminal domain of PrPC or the HD only was sorted basolat-
erally, indicating that this domain acts as a dominant sorting
signal. Vice versa, PrPC lacking the HD was found mainly at
the apical surface of MDCK cells.
The atypical and unique sorting behavior of PrPC might be of
pathophysiological relevance. Previous studies indicated that
expression of PrPF, a mutant devoid of the unstructured
N-terminal region including the HD (32–134), leads to cere-
bellar degeneration in transgenic mice. Importantly, the neu-
rotoxic potential of PrP variants correlated with the disruption
of the HD, which we identified as an important dominant
sorting domain for polarized trafficking. PrP mutants lacking
the N-terminal domain but containing the HD did not induce
neurodegeneration (12). Moreover, we show in this study that a
pathogenic mutation within the HD (PrP-AV3), which induces
neurodegeneration in transgenic mice, alters the sorting of
PrPC as well. Inactivation of the sorting signal might be due to
an alteration of either the primary sequence or the secondary
structure.
Another interesting aspect of our study is the observation
that the expression of Dpl has an impact on the sorting of PrPC.
Dpl induces cerebellar degeneration in transgenic mice, but its
neurotoxic potential can be antagonized by wildtype PrPC (10,
12). This effect is difficult to understand in the light of the
differential sorting of PrPC and Dpl. However, our co-expres-
sion studies may provide an explanation for the observations in
transgenic mice. Co-expression of Dpl prevents basolateral
sorting of PrPC and directs PrPC to the apical membrane,
possibly by masking the dominant sorting signal within the
HD. Thus, in cells expressing Dpl and PrPC, both proteins are
found at the same cellular locale, which could be a prerequisite
for a functional interaction. Unfortunately, we could not demon-
strate a direct interaction between PrPC and Dpl. A general
problem in PrP research is that no detergent conditions could be
identified which allow efficient and reproducible co-immunopre-
cipitation experiments for either PrPC or Dpl. It therefore will be
important to employ other techniques, such as cross-linking in
live cells or surface plasmon resonance with purified components,
to further analyze a possible interaction of PrPC and Dpl.
Our study provides experimental evidence that the HD is
required for the physiological trafficking of PrPC and reveals
missorting of neurotoxic PrP mutants with a deleted or mu-
tated HD. In transgenic animals expression of these mutants
induces neurodegeneration, but the mechanism of neuronal cell
death is still unknown. Based on our data, it is tempting to
speculate that PrP might acquire a neurotoxic potential by
missorting. However, it is equally plausible that a toxic gain of
function is a consequence of an aberrant or missing protein
interaction involving the hydrophobic domain.
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